Ajanta Pharma Limited

₹3,338As of Sun 8 Nov 2026, 12:00 UTC
NSE:AJANTPHARMHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 10.41%
Div yield 0.84%
ROE 27.53%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.23
PE TTM 33.05
TSR TTM 38.18%
Mkt cap ₹417.1B
ROIC 27.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹3,324
(0.44%)
141.99%
Hold 9|10|4|10|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
30.98
30.04
31.21
32.93
8.37%
5.61%
15.07%
17.23%
Revenue₹B
19.21
19.75
20.07
20.84
3.99%
1.24%
1.96%
7.87%
Peers (US$4.390B)
Cap (US$)
PE
5.568B
42.33x
5.236B
35.06x
4.369B
27.31x
Capital
TTM
5Y
10Y
Leveragex
0.512
0.097
0.089
EBIT/Intx
0.706
0.170
0.179
Own earn%
(9.36)
(10.09)
(12.21)
Sh yield%
47.80
3.83
4.49
Owners
Insiders/Inst%
5.64
70.98
Short interest%
1.15
SBC / revenue%
2.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
18